Literature DB >> 26163957

A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery.

Lugen Zuo1, Yi Li, Honggang Wang, Weiming Zhu, Wei Zhang, Jianfeng Gong, Ning Li, Jieshou Li.   

Abstract

BACKGROUND: Postoperative intra-abdominal septic complications are difficult to manage in Crohn's disease, which makes prevention especially important.
OBJECTIVE: The purpose of this study was to examine the risk factors for intra-abdominal septic complications after primary anastomosis for Crohn's disease and to seek a practical predictive index for intra-abdominal septic complications.
DESIGN: This was a retrospective study. SETTINGS: The study was conducted in a tertiary referral hospital. PATIENTS: Based on a computerized database of 344 patients with Crohn's disease who underwent primary anastomosis between 2004 and 2013, the patients were placed into an intra-abdominal septic complications group and a group without intra-abdominal septic complications. MAIN OUTCOME MEASURES: Univariate and multivariate analyses were performed to identify risk factors, and the predictive accuracy of possible predictors was assessed using receiver operating characteristic curves.
RESULTS: Overall, 39 patients (11.34%) developed intra-abdominal septic complications. Preoperative C-reactive protein level >10 mg/L was found to be an independent risk factor (p < 0.01) for intra-abdominal septic complications. For prediction of intra-abdominal septic complications, receiver operating characteristic curve analysis showed that a C-reactive protein cutoff of 14.50 mg/L provided negative and positive predictive values of 96.84% and 34.07%. In addition, the change in C-reactive protein levels over the 2 weeks before surgery was greater in the intra-abdominal septic complications group than the group with no intra-abdominal septic complications (p < 0.01), and the directions of change were opposite, upward in the former and downward in the latter. Apart from being a risk factor for intra-abdominal septic complications (p < 0.01), receiver operating characteristic curve analysis showed that the change in C-reactive protein levels before surgery had a negative predictive value for intra-abdominal septic complications of 98.66% and a positive predictive value of 76.09%. LIMITATIONS: This was a retrospective study.
CONCLUSIONS: Changes in C-reactive protein before surgical treatment of Crohn's disease could serve as a practical predictive index for postoperative intra-abdominal septic complications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26163957     DOI: 10.1097/DCR.0000000000000414

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  19 in total

1.  Outcome of Surgery for Coloduodenal Fistula in Crohn's Disease.

Authors:  Jianfeng Gong; Yao Wei; Lili Gu; Yi Li; Zhen Guo; Jing Sun; Chao Ding; Weiming Zhu; Ning Li; Jieshou Li
Journal:  J Gastrointest Surg       Date:  2015-12-30       Impact factor: 3.452

2.  Preoperative inflammation increases the risk of infection after elective colorectal surgery: results from a prospective cohort.

Authors:  Luigi De Magistris; Brice Paquette; David Orry; Olivier Facy; Giovanni Di Giacomo; Patrick Rat; Christine Binquet; Pablo Ortega-Deballon
Journal:  Int J Colorectal Dis       Date:  2016-06-29       Impact factor: 2.571

3.  The Presence of Postoperative Infectious Complications is Associated with the Risk of Early Postoperative Clinical Recurrence of Crohn's Disease.

Authors:  Zhen Guo; Lei Cao; Feilong Guo; Jianfeng Gong; Yi Li; Lili Gu; Weiming Zhu; Jieshou Li
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

4.  Glasgow prognostic score is a practical predictive index for postoperative intra-abdominal septic complications after bowel resection in Crohn's disease patients.

Authors:  Yibin Zhu; Haili Xu; Wei Liu; Weilin Qi; Xiaoyan Yang; Lingna Ye; Qian Cao; Wei Zhou
Journal:  Int J Colorectal Dis       Date:  2018-04-23       Impact factor: 2.571

5.  Compare risk factors associated with postoperative infectious complication in Crohn's disease with and without preoperative infliximab therapy: a cohort study.

Authors:  Shasha Tang; Xue Dong; Wei Liu; Weilin Qi; Lingna Ye; Xiaoyan Yang; Qian Cao; Xiaolong Ge; Wei Zhou
Journal:  Int J Colorectal Dis       Date:  2020-02-14       Impact factor: 2.571

6.  Impact of Preoperative Exclusive Enteral Nutrition on Postoperative Complications and Recurrence After Bowel Resection in Patients with Active Crohn's Disease.

Authors:  Honggang Wang; Lugen Zuo; Jie Zhao; Jianning Dong; Yi Li; Lili Gu; Jianfeng Gong; Qinghong Liu; Weiming Zhu
Journal:  World J Surg       Date:  2016-08       Impact factor: 3.352

7.  Large retroperitoneal abscess extended to the inferior right limb secondary to a perforated ileal Crohn's disease: the importance of the multidisciplinary approach.

Authors:  A Mascolino; G Scerrino; R Gullo; C Genova; G I Melfa; C Raspanti; T Fontana; N Falco; C Porrello; G Gulotta
Journal:  G Chir       Date:  2016 Jan-Feb

8.  Laparoscopic Surgery Can Reduce Postoperative Edema Compared with Open Surgery.

Authors:  Dong Guo; Jianfeng Gong; Lei Cao; Yao Wei; Zhen Guo; Weiming Zhu
Journal:  Gastroenterol Res Pract       Date:  2016-09-29       Impact factor: 2.260

9.  Preoperative prognostic nutritional index predicts postoperative surgical site infections in gastrointestinal fistula patients undergoing bowel resections.

Authors:  Qiongyuan Hu; Gefei Wang; Jianan Ren; Huajian Ren; Guanwei Li; Xiuwen Wu; Guosheng Gu; Ranran Li; Kun Guo; Youming Deng; Yuan Li; Zhiwu Hong; Lei Wu; Jieshou Li
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

10.  Validation and optimization of the Systemic Inflammation-Based modified Glasgow Prognostic Score in predicting postoperative outcome of inflammatory bowel disease: preliminary data.

Authors:  Chenyan Zhao; Chao Ding; Tingbin Xie; Tenghui Zhang; Xujie Dai; Yao Wei; Yi Li; Jianfeng Gong; Weiming Zhu
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.